Series A still flows
US startup funding slowed sharply in March, but eight Series A rounds last week still totaled $283M — showing selective capital is available (news.crunchbase.com). Latent Health led the week with an $80M clinical‑AI raise, underscoring investor appetite for targeted healthcare AI despite a tougher market (qubit.capital).
Latent’s Series A was co‑led by Spark Capital and Transformation Capital, with participation from General Catalyst, McKesson Ventures, Y Combinator and Conviction. (latenthealth.com) The company says its platform is live with roughly half of the top 20 U.S. health systems. (latenthealth.com) Latent’s product automates medication‑approval and prior‑authorization workflows so clinicians can get specialty drugs to patients faster, according to industry coverage. (mobihealthnews.com) Management told Forbes the business is targeting the specialty‑drug market and the company’s most recent financing implies about a $600 million private market valuation. (forbes.com) McKesson Ventures highlighted its participation and framed the investment as part of scaling clinical‑AI tools that integrate with health‑system workflows. (ventures.mckesson.com) Latent published the funding announcement on March 18, 2026 and said proceeds will be used to expand partnerships, grow headcount and deepen product integrations with health systems. (latenthealth.com)
